Illegal Sale of Toxic E-liquid Targeting Students in Vietnam

Regulations by 2FIRSTS.ai
Jan.16.2024
Illegal Sale of Toxic E-liquid Targeting Students in Vietnam
Vietnamese authorities have confirmed the illegal sale of e-liquids containing drugs to students in Hai Phong City.

According to a report by ANTD.VN on January 16th, the criminal investigation agency in Hai Phong City, Vietnam, has recently confirmed that Dam Viet Quang, residing in Vinh Bao town, is suspected of illegally selling e-liquid containing drugs, primarily targeting students and college students.

 

According to reports, the law enforcement authorities in Ninh Giang County have commenced a criminal investigation into the case and formally charged Dam Viet Quang, born in 2002. He stands accused of the crime of "illegal drug trafficking.

 

The investigation of the case revealed that the sold e-liquids are highly likely to contain drugs, and it involves students from multiple high schools and vocational education centers, causing widespread concern.

 

In a joint investigation, the police in Ninh Giang county discovered on December 25, 2023, in the Cống Sao area of Ninh Giang town, that a man named Phạm Văn L was selling two bottles of e-liquid to a high school student, which potentially contained drugs.

 

During police questioning, Phạm Văn L admitted to purchasing the e-liquids from Dam Viet Quang. Based on his statement, the authorities launched a thorough investigation and subsequently discovered 73.42 grams of dried plants containing the drug MDMB-4en-PINACA at Dam Viet Quang's residence. Additionally, they found some e-liquids that could potentially be laced with natural drugs.

 

Currently, the Ninh Giang County public security authorities are conducting a further investigation into this case to uncover the truth behind the entire incident. The incident has shed light on the issue of abuse in the e-cigarette market, particularly regarding sales to students, raising societal concerns about this problem.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Six Years of Data Show FDA Clearing PMTA Backlog
Six Years of Data Show FDA Clearing PMTA Backlog
FDA data from FY2020 to FY2025 show how the PMTA system for e-cigarette products evolved after an early surge of submissions created prolonged front-end delays. Millions of applications accumulated at the Acceptance stage before entering substantive review. Since 2023, the number of applications pending acceptance has declined sharply, and industry participants report shorter initial decision timelines in late 2025.
Feb.06
UK vape retailer VPZ to expand manufacturing, open 40 stores in 2026
UK vape retailer VPZ to expand manufacturing, open 40 stores in 2026
UK specialist vape retailer VPZ has launched a multi-million-pound investment programme to boost domestic production capacity and tighten supply-chain controls. The plan includes adding a fifth production line, opening 40 new stores across the UK in 2026 and creating hundreds of jobs, while establishing a bonded warehouse at its Edinburgh headquarters as regulation tightens and a vaping tax is planned.
Feb.02 by 2FIRSTS.ai
Fourth Circuit weighs federal preemption challenge to North Carolina’s vape sales restrictions
Fourth Circuit weighs federal preemption challenge to North Carolina’s vape sales restrictions
Vape manufacturers and sellers urged the U.S. Court of Appeals for the Fourth Circuit to find that the federal Food, Drug, and Cosmetic Act (FDCA) preempts North Carolina’s new law restricting the sale of certain e-cigarette/ENDS products.
Feb.03 by 2FIRSTS.ai
Juul, NJOY and Altria Clash Over Use of UCSF Public Documents in U.S. Patent Litigation
Juul, NJOY and Altria Clash Over Use of UCSF Public Documents in U.S. Patent Litigation
Juul Labs has asked a U.S. federal court to prevent NJOY and Altria from using documents stored in a public UCSF database in an ongoing patent lawsuit, arguing they are protected by attorney–client privilege. The defendants say the files have long been public and may contain evidence relevant to Juul’s patent conduct.
Dec.29 by 2FIRSTS.ai
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
Philip Morris International said it presented scientific evidence to the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee to support its ZYN nicotine pouches seeking a modified risk tobacco product designation, which would allow the company to communicate to adult smokers that switching completely to ZYN could reduce the risk of multiple smoking-related diseases.
Jan.26 by 2FIRSTS.ai
Scottish retailers call for tougher action as illegal vape black market “deepens,” SGF says
Scottish retailers call for tougher action as illegal vape black market “deepens,” SGF says
Scottish retailers, through the Scottish Grocers’ Federation (SGF), are calling for tougher action and more investment to tackle a “deepening black market” in illegal vapes, including illegal sales to children. SGF warns the problem will worsen, with negative health impacts, if incoming regulations on vaping product sales are not carefully crafted and if shopkeepers’ views are not heard.
Jan.14 by 2FIRSTS.ai